tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ARQT is currently covered by 11 analysts with an average price target of $28.75. This is a potential upside of $15.92 (124.08%) from yesterday's end of day stock price of $12.83.
Arcutis Biotherapeutics 's activity chart (see below) currently has 40 price targets and 76 ratings on display. The stock rating distribution of ARQT is 87.5% BUY and 12.5% HOLD.
Analysts average stock forecasts to be materialized ratio is 21.6% with an average time for these price targets to be met of 38.73 days.
Highest price target for ARQT is $21, Lowest price target is $15, average price target is $13.55.
Most recent stock forecast was given by JONATHAN BLOCK from GOLDMAN SACHS on 27-Feb-2025. First documented stock forecast 25-Feb-2020.
Currently out of the existing stock ratings of ARQT, 42 are a BUY (87.5%), 6 are a HOLD (12.5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$15
$1.31 (9.57%)
$11
4 days ago
(27-Feb-2025)
2/5 (40%)
$2.2 (17.19%)
55
Buy
$21
$7.31 (53.40%)
$20
5 days ago
(26-Feb-2025)
1/17 (5.88%)
$8.8 (72.13%)
44
Buy
$20
$6.31 (46.09%)
$20
5 days ago
(26-Feb-2025)
1/17 (5.88%)
$7.8 (63.93%)
102
Buy
$19
$5.31 (38.79%)
$19
5 days ago
(26-Feb-2025)
0/3 (0%)
$6.8 (55.74%)
Buy
7 days ago
(24-Feb-2025)
1/1 (100%)
$9.67 (36.73%)
27
What is ARQT (Arcutis Biotherapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on ARQT (Arcutis Biotherapeutics ) with a proven track record?
Which analyst has the most public recommendations on ARQT (Arcutis Biotherapeutics )?
Which analyst is the currently most bullish on ARQT (Arcutis Biotherapeutics )?
Which analyst is the currently most reserved on ARQT (Arcutis Biotherapeutics )?
